Souhaitez-vous accéder aux communiqués récents ?

 The company will now have the most advanced stimulator on the market, with enhanced features that increase the ease of use for physicians and integrate a patient management system ...

The company will now have the most advanced stimulator on the market, with enhancedfeatures that increase the ease of use for physicians and integrate a patient management system BrainsWay will be...

PATERSON, N.J., April 04, 2018 (GLOBE NEWSWIRE) -- The Trinitas-St. Joseph’s Behavioral Health Network is now offering Transcranial Magnetic Stimulation (TMS) as a treatment option for individuals...

Increased market demand and new leasing model continue to generate significant sales growth Total minimum committed revenue projection is record $27 million for year-end 2017, up 142% versus...

Phoenix Group becomes 7% shareholder Financing strengthens Brainsway's balance sheet and provides strong support for continued growth HACKENSACK, N.J., Dec. 12, 2017 (GLOBE NEWSWIRE) --...

Increased market demand and new leasing model continue to generate significant sales growth Recently signed contracts increased total minimum revenue projection by 21% over end of second quarter to...

Backlog revenues due to future lease agreements increased 27% to $19 million Quarterly revenues increased 11% Brainsway reports a receipt of a bank credit line for $6 million for a period of 42...

HACKENSACK, N.J., June 22, 2017 (GLOBE NEWSWIRE) -- Brainsway® USA Inc., a subsidiary of Brainsway Ltd. (TASE:BRIN), a leader in the advanced non-invasive treatment of brain disorders, today...

Brainsway will prepare a submission to the FDA to market the device for OCD Deep TMS treatment led to statistically significant and meaningful improvements in patients suffering from OCD Patients...

HACKENSACK, N.J., June 08, 2017 (GLOBE NEWSWIRE) -- In a release issued under the same headline on June 6th by Brainsway Ltd. (TASE:BRIN), please note in the fifth paragraph, the third...